drug · small molecule
patient view →cabozantinib
pre_registrationupdated 2mo agoby Lotus Pharmaceutical Co Ltd🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 41 investigational indications.
targets
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that